Teleflex Advances Long Coronary Stent Study, Keeping Cardiology Investors Watching
TipRanks (Tue, 31-Mar 12:30 PM ET)
Teleflex Reaffirms Strategy Amid Activist Pressure on Board
TipRanks (Fri, 27-Mar 3:45 PM ET)
Irenic Comments on Teleflex's Announcement That It Is Open to Strategic Alternatives
Business Wire (Fri, 27-Mar 2:31 PM ET)
Teleflex says Irenic falsely claimed company was not open for buyout offers
Seeking Alpha News (Fri, 27-Mar 1:42 PM ET)
Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution
Business Wire (Fri, 27-Mar 12:57 PM ET)
Teleflex urged to seek strategic alternatives, board changes by Irenic
Seeking Alpha News (Fri, 27-Mar 8:31 AM ET)
Market Chameleon (Fri, 27-Mar 4:11 AM ET)
Business Wire (Fri, 27-Mar 7:30 AM ET)
o9 Announces Teleflex Global Go-Live for Integrated Demand and Supply Planning
Business Wire (Thu, 12-Mar 8:02 AM ET)
Teleflex Sets Next Quarterly Dividend: What Investors Need to Know About This Key Announcement
Market Chameleon (Thu, 26-Feb 3:40 AM ET)
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Teleflex trades on the NYSE stock market under the symbol TFX.
As of March 31, 2026, TFX stock price climbed to $118.52 with 239,510 million shares trading.
TFX has a beta of 0.62, meaning it tends to be less sensitive to market movements. TFX has a correlation of 0.08 to the broad based SPY ETF.
TFX has a market cap of $5.24 billion. This is considered a Mid Cap stock.
Last quarter Teleflex reported $569 million in Revenue and $1.93 earnings per share. This fell short of revenue expectation by $-349 million and missed earnings estimates by -$1.81.
In the last 3 years, TFX traded as high as $276.43 and as low as $100.18.
The top ETF exchange traded funds that TFX belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.
TFX has underperformed the market in the last year with a return of -13.0%, while SPY returned +18.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TFX shares. However, TFX has outperformed the market in the last 3 month and 2 week periods, returning -2.3% and +8.5%, while SPY returned -5.4% and -2.8%, respectively. This indicates TFX has been having a stronger performance recently.
TFX support price is $112.28 and resistance is $117.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.